OliX Pharmaceuticals, Inc (KOSDAQ:226950)
South Korea
· Delayed Price · Currency is KRW 203,000
-4,000 (-1.93%)
Mar 9, 2026, 3:30 PM KST
OliX Pharmaceuticals Revenue
OliX Pharmaceuticals had revenue of 2.91B KRW in the quarter ending September 30, 2025, with 1,002.56% growth. This brings the company's revenue in the last twelve months to 10.18B, down -36.91% year-over-year. In the year 2024, OliX Pharmaceuticals had annual revenue of 5.68B, down -66.73%.
Revenue (ttm)
10.18B
Revenue Growth
-36.91%
P/S Ratio
402.55
Revenue / Employee
n/a
Employees
n/a
Market Cap
4,098.55B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| D&D Pharmatech | 8.36B |
| PharmaResearch | 496.03B |
| SK bioscience | 624.03B |
| Voronoi | 7.49B |
| Peptron | 6.19B |
| Hugel | 425.10B |
| HLB Co., Ltd. | 80.73B |
| Orum Therapeutics | 25.48M |